Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11400132 Ophthalmic compositions comprising ciclosporin

Patent 11400132 was granted and assigned to Novaliq on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Novaliq
0
Date Filed
October 13, 2020
0
Date of Patent
August 2, 2022
0
Patent Applicant
‌
Novaliq
0
Patent Application Number
17069417
0
Patent Citations
‌
US Patent 10064944 Liquid pharmaceutical composition for the treatment of a posterior eye disease
‌
US Patent 10130707 Topical pharmaceutical composition based on semifluorinated alkanes
‌
US Patent 10273298 Stabilized antibody compositions
‌
US Patent 10369117 Compositions comprising mixtures of semifluorinated alkanes
0
‌
US Patent 10449164 Methods of treating ocular disorders using semifluorinated alkanes
0
‌
US Patent 10507132 Topical administration method
‌
US Patent 10525062 Pharmaceutical composition for treatment of increased intraocular pressure
‌
US Patent 10555953 Pharmaceutical composition for treatment of increased intraocular pressure
‌
US Patent 10576154 Semifluorinated alkane compositions
‌
US Patent 10813976 Ophthalmic compositions comprising ciclosporin
•••
Patent Citations Received
‌
US Patent 12128010 Semifluorinated compounds and their compositions
0
Patent Inventor Names
Ralf Grillenberger
0
Johan Engblom
0
Frank Löscher
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11400132
0
Patent Primary Examiner
‌
Christina Bradley
0

Find more entities like US Patent 11400132 Ophthalmic compositions comprising ciclosporin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.